Related Experiment Videos
Structure, process and outcomes of chest pain units established in the ESCAPE trial
Jane Arnold1, Steve Goodacre, Francis Morris
1Medical Care Research Unit, University of Sheffield, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK. j.a.arnold@sheffield.ac.uk
Insights
Chest pain units (CPUs) safely manage acute chest pain patients in the NHS, with most discharged after assessment. The ESCAPE trial showed CPUs can be established, but activity varies between hospitals.
Area of Science:
- Cardiology
- Health Services Research
Background:
- Chest pain units (CPUs) offer improved outcomes and reduced costs for acute chest pain care.
- The ESCAPE (Effectiveness and Safety of Chest Pain Assessment to Prevent Emergency Admissions) trial evaluated CPU establishment in the NHS.
Purpose of the Study:
- To detail the structure, processes, and patient outcomes within Chest Pain Units (CPUs) participating in the ESCAPE Trial.
- To assess the feasibility and safety of implementing standardized CPU care across diverse NHS hospitals.
Main Methods:
- Seven NHS hospitals were randomized to establish CPUs using standardized protocols.
- Low-risk patients received biochemical cardiac marker and exercise treadmill testing.
- A 30-day follow-up monitored adverse events, including chest pain-related readmissions, myocardial infarction, and death.
Main Results:
- Seven CPUs managed 1644 patients in their first year, with activity ranging from 1 to 7 patients per 1000 emergency attendances.
- 83% of patients were discharged post-CPU assessment, with a low adverse event rate of 1.7% among discharged patients.
- Hospital size and patient selection influenced CPU activity levels.
Conclusions:
- Chest pain unit (CPU) care is safely implementable in various NHS settings, facilitating the discharge of most patients.
- Significant variation exists in patient volume and case mix across different CPU units.
- Further investigation is needed to understand and address the observed variations in CPU activity.
Background:
Chest pain units (CPUs) provide a system of care for patients with acute chest pain that can improve outcomes while reducing health service costs. The Effectiveness and Safety of Chest Pain Assessment to Prevent Emergency Admissions (ESCAPE) multicentre trial was undertaken to determine whether CPUs could be successfully established throughout the National Health Service (NHS).
Aim:
To describe the structure, processes and outcomes of patients managed by CPUs in the ESCAPE Trial.
Method:
7 of 14 participating hospitals were randomly allocated to establish CPU care. Each hospital set up a CPU using standardised protocols to provide biochemical cardiac marker and exercise treadmill testing for low-risk patients. Research staff then followed up patients for 30 days to identify any adverse events, defined as chest pain-related readmission to hospital for more than 48 h, non-fatal myocardial infarction and all deaths.
Results:
The 7 units managed a total of 1644 patients during their first year of operation. Activity varied from 1 to 7 patients per 1000 adult emergency department attendances. Overall, 1374 (83%) patients were discharged after CPU assessment, with 23 (1.7%) adverse events recorded among those discharged. Some, but not all, of the variation in activity could be attributed to hospital size and patient selection.
Conclusion:
CPU care can be instituted in a safe manner at a variety of NHS hospitals, with most patients being discharged after assessment. However, there is variation in the number and type of patients managed by the different units. Further research is required to identify reasons for variation in CPU activity.
Related Concept Videos
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Angina III: Clinical Manifestations and Assessment
Angina V: Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies